Somatic mitochondrial DNA mutations in cortex and substantia nigra in aging and Parkinson's disease
- PMID: 14675733
- DOI: 10.1016/s0197-4580(03)00037-x
Somatic mitochondrial DNA mutations in cortex and substantia nigra in aging and Parkinson's disease
Abstract
Oxidative damage to mitochondrial DNA (mtDNA) increases with age in the brain and can induce G:C to T:A and T:A to G:C point mutations. Though rare at any particular site, multiple somatic mtDNA mutations induced by oxidative damage or by other mechanisms may accumulate with age in the brain and thus could play a role in aging and neurodegenerative diseases. However, no prior study has quantified the total burden of mtDNA point mutation subtypes in the brain. Using a highly sensitive cloning and sequencing strategy, we find that the aggregate levels of G:C to T:A and T:A to G:C transversions and of all point mutations increase with age in the frontal cortex (FCtx). In the substantia nigra (SN), the aggregate levels of point mutations in young controls are similar to the levels in the SN or FCtx of elderly subjects. Extrapolation from our data suggests an average of 2.7 (FCtx) to 3.2 (SN) somatic point mutations per mitochondrial genome in elderly subjects. There were no significant differences between Parkinson's disease (PD) patients and age-matched controls in somatic mutation levels. These results indicate that individually rare mtDNA point mutations reach a high aggregate burden in FCtx and SN of elderly subjects.
Comment in
-
Response to Simon et al.Acta Neuropathol Commun. 2017 Apr 29;5(1):34. doi: 10.1186/s40478-017-0434-8. Acta Neuropathol Commun. 2017. PMID: 28454558 Free PMC article. No abstract available.
Similar articles
-
High aggregate burden of somatic mtDNA point mutations in aging and Alzheimer's disease brain.Hum Mol Genet. 2002 Jan 15;11(2):133-45. doi: 10.1093/hmg/11.2.133. Hum Mol Genet. 2002. PMID: 11809722
-
Mitochondrial DNA deletions/rearrangements in parkinson disease and related neurodegenerative disorders.J Neuropathol Exp Neurol. 2002 Jul;61(7):634-9. doi: 10.1093/jnen/61.7.634. J Neuropathol Exp Neurol. 2002. PMID: 12125742
-
Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.Brain. 2013 Aug;136(Pt 8):2369-78. doi: 10.1093/brain/awt196. Brain. 2013. PMID: 23884809
-
Detrimental deletions: mitochondria, aging and Parkinson's disease.Bioessays. 2006 Oct;28(10):963-7. doi: 10.1002/bies.20471. Bioessays. 2006. PMID: 16998822 Review.
-
Mechanism of somatic mitochondrial DNA mutations associated with age and diseases.Biochim Biophys Acta. 1995 May 24;1271(1):177-89. doi: 10.1016/0925-4439(95)00026-z. Biochim Biophys Acta. 1995. PMID: 7599206 Review.
Cited by
-
Oxidative Stress: A Key Modulator in Neurodegenerative Diseases.Molecules. 2019 Apr 22;24(8):1583. doi: 10.3390/molecules24081583. Molecules. 2019. PMID: 31013638 Free PMC article. Review.
-
DNA damage induces nuclear translocation of parkin.J Biomed Sci. 2009 Jul 17;16(1):67. doi: 10.1186/1423-0127-16-67. J Biomed Sci. 2009. PMID: 19615059 Free PMC article.
-
Mitochondrial dysfunction in Parkinson's disease: pathogenesis and neuroprotection.Parkinsons Dis. 2010 Dec 26;2011:617472. doi: 10.4061/2011/617472. Parkinsons Dis. 2010. PMID: 21234411 Free PMC article.
-
Mitochondrial approaches for neuroprotection.Ann N Y Acad Sci. 2008 Dec;1147:395-412. doi: 10.1196/annals.1427.027. Ann N Y Acad Sci. 2008. PMID: 19076459 Free PMC article. Review.
-
The Alzheimer's disease mitochondrial cascade hypothesis: an update.Exp Neurol. 2009 Aug;218(2):308-15. doi: 10.1016/j.expneurol.2009.01.011. Epub 2009 Jan 29. Exp Neurol. 2009. PMID: 19416677 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical